acetohexamide

Uses your system voice; voice and rate in settings.

Q4673274Snapshot

≈ 1 min read

Names in other languages

  • lvacetoheksamīds
  • Englishacetohexamide
  • EspañolAcetohexamida
  • shAcetoheksamid
  • СрпскиAcetoheksamid
  • Italianoacetoesamide
  • Portuguêsacetoexamida
  • 日本語アセトヘキサミド

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.

Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.

Mechanism of action

Acetohexamide binds to an ATP-sensitive K + (K ATP ) channel on the cell membrane of pancreatic beta cells. This inhibits the outflux of potassium, which causes the membrane potential to become more positive. This depolarization in turn opens voltage-gated calcium channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of insulin.

Risks

Sulfonylureas, especially first-generation sulfonylureas such as Acetohexamide, can cause severe hypoglycemia and increase the risk of adverse cardiovascular events.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1357901449 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.